|Day's Range||311.91 - 314.53|
|52 Week Range||256.08 - 320.48|
|PE Ratio (TTM)||N/A|
|Expense Ratio (net)||0.25%|
In 1Q17, Bio-Rad Laboratories’ (BIO) Life Science segment reported revenues of ~$174.3 million, which represents a YoY rise of ~5.1%.
MPC's valuations are above the peer averages likely because it's now in the process of restructuring its organization to unlock value.
In 1Q17, WellCare Health Plans (WCG) reported revenues of ~$3.9 billion, which totals year-over-year growth of around 11.7%.